1. Home
  2. GTBP vs AVX Comparison

GTBP vs AVX Comparison

Compare GTBP & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • AVX
  • Stock Information
  • Founded
  • GTBP 1965
  • AVX 2017
  • Country
  • GTBP United States
  • AVX Canada
  • Employees
  • GTBP N/A
  • AVX N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • AVX Metal Fabrications
  • Sector
  • GTBP Health Care
  • AVX Industrials
  • Exchange
  • GTBP Nasdaq
  • AVX Nasdaq
  • Market Cap
  • GTBP 2.6M
  • AVX 2.4M
  • IPO Year
  • GTBP N/A
  • AVX 2021
  • Fundamental
  • Price
  • GTBP $0.74
  • AVX $1.64
  • Analyst Decision
  • GTBP Strong Buy
  • AVX
  • Analyst Count
  • GTBP 1
  • AVX 0
  • Target Price
  • GTBP $11.00
  • AVX N/A
  • AVG Volume (30 Days)
  • GTBP 1.2M
  • AVX 402.0K
  • Earning Date
  • GTBP 11-14-2025
  • AVX 11-14-2025
  • Dividend Yield
  • GTBP N/A
  • AVX N/A
  • EPS Growth
  • GTBP N/A
  • AVX N/A
  • EPS
  • GTBP N/A
  • AVX N/A
  • Revenue
  • GTBP N/A
  • AVX $1,319,011.00
  • Revenue This Year
  • GTBP N/A
  • AVX N/A
  • Revenue Next Year
  • GTBP N/A
  • AVX N/A
  • P/E Ratio
  • GTBP N/A
  • AVX N/A
  • Revenue Growth
  • GTBP N/A
  • AVX 8001.54
  • 52 Week Low
  • GTBP $0.54
  • AVX $1.43
  • 52 Week High
  • GTBP $4.10
  • AVX $38.88
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 53.14
  • AVX N/A
  • Support Level
  • GTBP $0.62
  • AVX N/A
  • Resistance Level
  • GTBP $1.15
  • AVX N/A
  • Average True Range (ATR)
  • GTBP 0.09
  • AVX 0.00
  • MACD
  • GTBP 0.01
  • AVX 0.00
  • Stochastic Oscillator
  • GTBP 34.74
  • AVX 0.00

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: